phase readout
saveNCT07265479: A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Organon and Co. Phase: PHASE3. Conditions: Atopic Dermatitis
view source ↗
comments(0)
5-min edit window · permanent after that